Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Taysha Gene Therapies (TSHA) Gross Profit: 2020-2024

Historic Gross Profit for Taysha Gene Therapies (TSHA) over the last 5 years, with Dec 2024 value amounting to $8.3 million.

  • Taysha Gene Therapies' Gross Profit fell 100.84% to -$15,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 36.51%. This contributed to the annual value of $8.3 million for FY2024, which is 46.07% down from last year.
  • Taysha Gene Therapies' Gross Profit amounted to $8.3 million in FY2024, which was down 46.07% from $15.5 million recorded in FY2023.
  • Over the past 5 years, Taysha Gene Therapies' Gross Profit peaked at $15.5 million during FY2023, and registered a low of -$1.4 million during FY2021.
  • Moreover, its 3-year median value for Gross Profit was $8.3 million (2024), whereas its average is $8.8 million.
  • Per our database at Business Quant, Taysha Gene Therapies' Gross Profit slumped by 5,000.00% in 2021 and then spiked by 517.55% in 2023.
  • Taysha Gene Therapies' Gross Profit (Yearly) stood at -$28,000 in 2020, then tumbled by 5,000.00% to -$1.4 million in 2021, then skyrocketed by 275.21% to $2.5 million in 2022, then spiked by 517.55% to $15.5 million in 2023, then tumbled by 46.07% to $8.3 million in 2024.